Gossamer Bio Inc (NASDAQ: GOSS) started the day on Wednesday, with a price decrease of -0.06% at $0.89, before settling in for the price of $0.89 at the close. Taking a more long-term approach, GOSS posted a 52-week range of $0.45-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 11.99%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 77.55%. This publicly-traded company’s shares outstanding now amounts to $225.41 million, simultaneously with a float of $186.93 million. The organization now has a market capitalization sitting at $201.12 million.
Gossamer Bio Inc (GOSS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Gossamer Bio Inc’s current insider ownership accounts for 17.37%, in contrast to 66.60% institutional ownership. According to the most recent insider trade that took place on Jun 24 ’24, this organization’s Chief Medical Officer sold 1,908 shares at the rate of 0.66, making the entire transaction reach 1,260 in total value, affecting insider ownership by 196,891. Preceding that transaction, on Jun 21 ’24, Company’s President & CEO bought 372,000 for 0.67, making the whole transaction’s value amount to 250,282. This particular insider is now the holder of 5,408,073 in total.
Gossamer Bio Inc (GOSS) Earnings and Revenue Records
Gossamer Bio Inc’s EPS increase for this current 12-month fiscal period is 77.55% and is forecasted to reach -0.70 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.20% through the next 5 years, which can be compared against the 11.99% growth it accomplished over the previous five years trading on the market.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Let’s observe the current performance indicators for Gossamer Bio Inc (GOSS). It’s Quick Ratio in the last reported quarter now stands at 8.21. The Stock has managed to achieve an average true range (ATR) of 0.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.10.
In the same vein, GOSS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.40, a figure that is expected to reach -0.15 in the next quarter, and analysts are predicting that it will be -0.70 at the market close of one year from today.
